Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03474640
Title Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Shanghai Junshi Bioscience Co.,Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarcoma Oncology Research Center Santa Monica California 90404 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
University of Miami Hospital Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Florida Cancer Specialists Sarasota Florida 34238 United States Details
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic-Rochester Rochester Minnesota 55901 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
University Hospitals Seidman Cancer Center Cleveland Ohio 44101 United States Details
Rhode Island Hospital Providence Rhode Island 02906 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field